Literature DB >> 25664396

Gene polymorphisms of interleukin 28B and the risk to chronic hepatitis B virus infection in Thai.

I Kimkong1, J Chankaew, A Kunanopparat, N Hirankarn, P Tangkijvanich.   

Abstract

In this study, we aimed to evaluate the effect of two single nucleotide polymorphisms (SNPs) of interleukin 28B (IL28B) (rs12979860C/T and rs8099917G/T) on chronic hepatitis B virus (CHB) infection in Thai population. We studied 375 subjects: 83 CHB with hepatocellular carcinoma (HCC) patients, 128 CHB without HCC and 164 individuals with self-limited HBV infection, by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and TaqMan allelic discrimination assay. Results revealed significant risk of IL28B rs8099917T allele associated with CHB without HCC compared with self-limited HBV [odds ratio (OR) (95% confidence interval (CI)) = 2.56 (1.08-6.28), P = 0.019]. The effect of this T allele was similar to that of an autosomal recessive gene in the presence of TT genotype compared with GG and GT genotype [OR (95% CI) = 2.70 (1.11-6.77), P = 0.016, P (logistic regression) = 0.048]. The two locus haplotype analysis of the two IL28B SNP loci did not show any association with CHB (P > 0.05). In conclusion, these results suggested a IL28B rs8099917T allele predispose for susceptibility to chronic HBV infection but not leading to HCC in Thai population.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  chronic hepatitis B; hepatocellular carcinoma; interleukin 28B; single nucleotide polymorphisms

Mesh:

Substances:

Year:  2015        PMID: 25664396     DOI: 10.1111/tan.12517

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  8 in total

1.  Genome-Wide Association Study for Chronic Hepatitis B Infection in the Thai Population.

Authors:  Saeideh Ashouri; Seik-Soon Khor; Yuki Hitomi; Hiromi Sawai; Nao Nishida; Masaya Sugiyama; Yosuke Kawai; Nawarat Posuwan; Pisit Tangkijvanich; Piyawat Komolmit; Makoto Tsuiji; Vorasuk Shotelersuk; Yong Poovorawan; Masashi Mizokami; Katsushi Tokunaga
Journal:  Front Genet       Date:  2022-06-13       Impact factor: 4.772

2.  A meta-analysis of the association between IL28B polymorphisms and infection susceptibility of hepatitis B virus in Asian population.

Authors:  Jing Chen; Wei Wang; Xiaoguang Li; Jie Xu
Journal:  BMC Gastroenterol       Date:  2015-05-12       Impact factor: 3.067

3.  Deltex1 Polymorphisms Are Associated with Hepatitis B Vaccination Non-Response in Southwest China.

Authors:  Bin Xie; Penghui Zhang; Menggang Liu; Wei Zeng; Juntao Yang; Hongming Liu
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

4.  Association between TLR7 copy number variations and hepatitis B virus infection outcome in Chinese.

Authors:  Fang Li; Xu Li; Gui-Zhou Zou; Yu-Feng Gao; Jun Ye
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

5.  The influence of interleukin 28B polymorphisms on the risk of hepatocellular carcinoma among patients with HBV or HCV infection: An updated meta-analysis.

Authors:  Shaoyou Qin; Jiangbin Wang; Changyu Zhou; Yan Xu; Yonggui Zhang; Xu Wang; Song Wang
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

6.  Association between IL28B Polymorphisms and Outcomes of Hepatitis B Virus Infection: A meta-analysis.

Authors:  Jingyu Zhao; Xinyue Zhang; Liwei Fang; Hong Pan; Jun Shi
Journal:  BMC Med Genet       Date:  2020-05-01       Impact factor: 2.103

Review 7.  Meta-analysis of associations of interleukin-28B polymorphisms rs8099917 and rs12979860 with development of hepatitis virus-related hepatocellular carcinoma.

Authors:  Yu Zhang; Shao-Liang Zhu; Jie Chen; Le-Qun Li
Journal:  Onco Targets Ther       Date:  2016-05-30       Impact factor: 4.147

8.  Association of TLR3 (rs3775291) and IL-10 (rs1800871) gene polymorphisms with susceptibility to Hepatitis B infection: A meta-analysis.

Authors:  Susu Ye; Xinlei Zhang; Yu Bao Zhang; Xintao Tian; Ailing Liu; Changxing Cui; Lei Shi; Di Xia
Journal:  Epidemiol Infect       Date:  2020-09-11       Impact factor: 2.451

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.